metformin and thioacetamide

metformin has been researched along with thioacetamide in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (66.67)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Glen, RC; Lowe, R; Mitchell, JB1
Ekins, S; Williams, AJ; Xu, JJ1
Abdel-Salam, LO; Al-Ani, B; Al-Hashem, F; Al-Humayed, S; Alfaifi, M; Amin, SN; Ellatif, MA; Haidara, MA; Hassan, S; Kamar, SS; Mansy, SS1
Al-Ani, B; Albawardi, A; Alqahtani, SM; Alshahrani, MY; Bayoumy, NM; Ebrahim, HA; Haidara, MA; Kamar, SS; ShamsEldeen, AM1
Hafez, DM; Mohamed, EK1

Other Studies

6 other study(ies) available for metformin and thioacetamide

ArticleYear
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
Predicting phospholipidosis using machine learning.
    Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5

    Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Metformin inhibits mTOR-HIF-1α axis and profibrogenic and inflammatory biomarkers in thioacetamide-induced hepatic tissue alterations.
    Journal of cellular physiology, 2019, Volume: 234, Issue:6

    Topics: Animals; Biomarkers; Chronic Disease; Hepatocytes; Hypoxia-Inducible Factor 1, alpha Subunit; Inflammation; Liver; Liver Cirrhosis; Male; Metformin; Protective Agents; Rats; Signal Transduction; Thioacetamide; TOR Serine-Threonine Kinases

2019
Metformin Suppresses Thioacetamide-Induced Chronic Kidney Disease in Association with the Upregulation of AMPK and Downregulation of Oxidative Stress and Inflammation as Well as Dyslipidemia and Hypertension.
    Molecules (Basel, Switzerland), 2023, Mar-18, Volume: 28, Issue:6

    Topics: AMP-Activated Protein Kinases; Animals; Down-Regulation; Dyslipidemias; Fibrosis; Hypertension; Inflammation; Liver; Liver Cirrhosis; Metformin; Oxidative Stress; Rats; Renal Insufficiency, Chronic; Thioacetamide; Tissue Inhibitor of Metalloproteinase-1; Up-Regulation

2023
Gallic acid and metformin co-administration reduce oxidative stress, apoptosis and inflammation via Fas/caspase-3 and NF-κB signaling pathways in thioacetamide-induced acute hepatic encephalopathy in rats.
    BMC complementary medicine and therapies, 2023, Jul-25, Volume: 23, Issue:1

    Topics: Animals; Apoptosis; Caspase 3; Gallic Acid; Hepatic Encephalopathy; Inflammation; Metformin; NF-kappa B; Oxidative Stress; Rats; Rats, Wistar; Signal Transduction; Thioacetamide

2023